Back to Search Start Over

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Details

Language :
English
ISSN :
01406736 and 1474547X
Volume :
403
Issue :
10445
Database :
Supplemental Index
Journal :
The Lancet
Publication Type :
Periodical
Accession number :
ejs66687437
Full Text :
https://doi.org/10.1016/S0140-6736(24)00885-7